Will this change impact inpatient care today?
No. Nothing is changing today. Dana-Farber's current collaboration with Brigham and Women's Hospital (BWH) for adult inpatient medical and surgical oncology care will continue for several more years.
The inpatient facilities and clinical collaborations that are in place today through our relationship with BWH provide excellent patient care and outcomes. We have deep respect and profound appreciation for our Brigham and Women's Hospital colleagues, and, together, we are committed to providing the same excellent care we provide now throughout the duration of our current collaboration.
Once Dana-Farber's clinical collaboration with Beth Israel Deaconess is operational, patient care will continue to be led by Dana-Farber clinicians.
Will my care team change?
Patient care remains the same today. We do not expect any changes for several years. Dana-Farber and Brigham and Women's Hospital are committed to providing the same excellent care we provide now throughout the duration of our collaboration.
Will I be able to stay with my provider?
Patients can always choose their provider. Many hospitals and doctors in the region and around the world refer their patients to us. That won't change and patients will always have the option of choosing their doctor.
In the future collaboration, how will I get information from my care team? How will my care team share information with each other?
While it is several years before our future collaboration goes into effect, we are working now to set up patient-oriented communications and access for all care team members to your latest information. When the future collaboration goes into effect, we will ensure a seamless integration of patient records and a consistent flow of information, for both our patients and your care teams.
Does the future collaboration affect Dana-Farber's regional campuses outside of Boston?
No. Our future collaboration with BIDMC only applies to the Longwood Medical Area and Chestnut Hill locations. There are no planned changes to our regional campuses in Brighton, Weymouth, Foxborough, Milford, Merrimack Valley, or Londonderry.
Will there be any changes to outpatient care at the Yawkey Center or Chestnut Hill?
No. Patients who receive outpatient care at our Yawkey Center or Chestnut Hill locations will continue to do so without interruption.
Will this impact pediatric care?
Our joint program for pediatric cancer care with Boston Children's Hospital will continue without change or interruption.
Where is the new hospital going to be located?
Pending regulatory approvals, the proposed new inpatient hospital will be located on Brookline Avenue at the current site of the Joslin Diabetes Center across the street from Dana-Farber's Yawkey Center. It will be a brand new building, and will be adjacent to both Dana-Farber and BIDMC Longwood campuses.
